Instructions for taking VENCLYXTO®
Click on Getting Started on VENCLYXTO and VENCLYXTO Patient Booklet below to learn about how VENCLYXTO® works,
and how and when to take it.
{{noResultsFoundText}}
{{downloadLibraryItem.fileTitle}}
{{downloadLibraryItem.fileDescription}}
{{itemTag.name}}
When administering VENCLYXTO®, advise patients as follows:
Be adequately hydrated every day when taking VENCLYXTO® to reduce the risk of TLS.
Adequate hydration is particularly important 2 days before and on the day of the first dose, and every time the dose is increased. The recommended volume is 1.5–2 L of water (6–8 glasses) each day.
Take VENCLYXTO® orally once daily with a meal and water at approximately the same time each day.
Swallow the VENCLYXTO® tablets whole.
The tablets should not be chewed, crushed, or broken before swallowing.
In case of a missed dose, advise patients as follows:
If a patient misses a dose within 8 hours from the time it is usually taken:
The patient should take the missed dose right away and take the next dose as usual.
If a patient misses a dose by more than 8 hours:
The patient should not take the missed dose and should take the next dose at the usual time.
If a patient vomits following dosing:
No additional dose should be taken that day. The next prescribed dose should be taken at the usual time the next day.
CLL=chronic lymphocytic leukaemia; 2L+=second line + later lines of therapy; HR=hazard ratio; CI=confidence interval; PFS=progression-free survival; BR=bendamustine + rituximab; VEN+R=VENCLYXTO® + rituximab; TLS=tumour lysis syndrome.
I want to find out more
about VENCLYXTO® in CLL
Reference: 1. VENCLYXTO® Summary of Product Characteristics, available at www.medicines.ie
IE-VNCCLL-230072 | Date of preparation: December 2023
